Pfizer Inc. said participants were showing mild-to-moderate side effects when given either the company’s experimental coronavirus vaccine or a placebo in an ongoing late-stage study.

U.S. drugmaker Merck & Co. Inc. began recruiting participants to the company’s early-stage Covid-19 vaccine study, according to the government database clinicaltrials.gov.